Your browser doesn't support javascript.
loading
The AP-1 transcription factor Fosl-2 drives cardiac fibrosis and arrhythmias under immunofibrotic conditions.
Stellato, Mara; Dewenter, Matthias; Rudnik, Michal; Hukara, Amela; Özsoy, Çagla; Renoux, Florian; Pachera, Elena; Gantenbein, Felix; Seebeck, Petra; Uhtjaerv, Siim; Osto, Elena; Razansky, Daniel; Klingel, Karin; Henes, Joerg; Distler, Oliver; Blyszczuk, Przemyslaw; Kania, Gabriela.
Afiliación
  • Stellato M; Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Dewenter M; Institute of Experimental Cardiology, University Hospital, Heidelberg, Germany.
  • Rudnik M; Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Hukara A; Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Özsoy Ç; Institute for Biomedical Engineering and Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Zurich, Zurich, Switzerland.
  • Renoux F; Institute for Biomedical Engineering, Department of Information Technology and Electrical Engineering, ETH Zurich, Zurich, Switzerland.
  • Pachera E; Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Gantenbein F; Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Seebeck P; Zurich integrative Rodent Physiology, University of Zurich, Zurich, Switzerland.
  • Uhtjaerv S; Zurich integrative Rodent Physiology, University of Zurich, Zurich, Switzerland.
  • Osto E; Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
  • Razansky D; Institute of Clinical Chemistry, University Hospital Zurich, Zurich, Switzerland.
  • Klingel K; Institute for Biomedical Engineering and Institute of Pharmacology and Toxicology, Faculty of Medicine, University of Zurich, Zurich, Switzerland.
  • Henes J; Institute for Biomedical Engineering, Department of Information Technology and Electrical Engineering, ETH Zurich, Zurich, Switzerland.
  • Distler O; Cardiopathology, Institute for Pathology and Neuropathology, University Hospital Tubingen, Tubingen, Germany.
  • Blyszczuk P; Internal Medicine II, Division of Rheumatology, University Hospital Tubingen, Tubingen, Germany.
  • Kania G; Center of Experimental Rheumatology, Department of Rheumatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Commun Biol ; 6(1): 161, 2023 02 09.
Article en En | MEDLINE | ID: mdl-36759717
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factor de Transcripción AP-1 / Cardiomiopatías Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Commun Biol Año: 2023 Tipo del documento: Article País de afiliación: Suiza
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factor de Transcripción AP-1 / Cardiomiopatías Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Animals / Humans Idioma: En Revista: Commun Biol Año: 2023 Tipo del documento: Article País de afiliación: Suiza